Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin immediate-release versus extended-release pharmacokinetics in pediatric acute otitis media
2014-004164-38Phase 2
- Sponsor
- Pfizer
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of azithromycin in acute otitis media (AOM) (2 arms), sponsored by Pfizer. Primary endpoint: Area under the curve from time zero to 72 hours.
02
Drugs
azithromycin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2014-004164-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004164-38.